Dr. Reddy's Laboratories Ltd. Press Release Nov 28 2024
Filed with NSE · · 4 pages · English
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Oct 28 2024
- Press Release Oct 08 2024
- Press Release Oct 02 2024
- Press Release Jul 29 2024
- Press Release Jul 18 2024
Later from Dr. Reddy's Laboratories
- Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
- Press Release Mar 13 2025
- Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
- Press Release Apr 24 2025
- Dr. Reddy’s Q4 & Full Year FY25 Financial Results
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories